Attenuate the Stress Response in Laparoscopic Cholecystectomy
Starting soon · Phase 4
Conditions studied: Laparoscopic Cholecystectomy Surgery
In brief
Aims of this study are to compare the effectiveness of dexmedetomidine versus fentanyl-midazolam in attenuating hemodynamic stress response during laparoscopic cholecystectomy (mainly HR). And to assess the recovery profile, the pain and opioid requirements, the sedation profile, and any adverse events during the first 24 hrs postoperatively
Key facts
- Study ID
- NCT07425444
- Run by
- Assiut University
- People needed
- 50
- Starts
- 2026-02-01
- Expected to finish
- 2027-04-01
- Last updated by the study team
- 2026-02-20
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18-65 years.
- Both sexes.
- American Society of Anesthesiology (ASA) physical status I - II.
You may not qualify if…
- Known allergy to study drugs.
- Uncontrolled, non-correctable comorbidities (hepatic, renal or cardiac such as hypertension \& Arrhythmia ).
- History of psychiatric illness or substance abuse.
- Pregnancy or lactation
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.